Carregant...

Selective effects of a therapeutic protein targeting tumor necrosis factor-alpha on cytochrome P450 regulation during infectious colitis: implications for disease-dependent drug–drug interactions

We studied the impact of administering XPro1595, a novel antagonist of soluble tumor necrosis factor-α(TNFα), on the regulation of hepatic cytochrome P450 enzymes in the Citrobacter rodentium model of infectious colitis. XPro1595 was administered subcutaneously every 3 days throughout the infection,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Nyagode, Beatrice A, Jahangardi, Roya, Merrell, Matthew D, Tansey, Malú G, Morgan, Edward T
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3972819/
https://ncbi.nlm.nih.gov/pubmed/24707356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.27
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!